Home
About Us
Inside Absci
Team
Our Values
Blog
In the News
Events
Our Technology
Our Science
Posters
Manuscripts
Science Blogs
All
Pipeline
Partner With Us
Investors
Careers
Life at Absci
Current Openings
Internships
Contact Us
In the News
July 2, 2024
GEN: Absci Eyes Busy 2025 as Lead AI-Designed Candidate Heads for Clinic
Load More
Media Highlights
Press Releases
Absci’s Sean McClain and Gregory Hannum featured on Gradient Dissent podcast
KPTV Fox 12: New biotech company in Vancouver hopes to reinvent the way drugs are made
The Columbian: Thank you, E. coli: Vancouver’s Absci uses bacteria to make ‘exciting’ drug discoveries
BioPharma Reporter: Synthetic biology innovator opens new campus to speed up drug discovery
Absci founder & CEO Sean McClain on The Bio Report podcast
Pages:
1
2
3
4
5
6
7
8
9
10
Load More
Looking for more resources?
View Events
View Blog
You’re leaving the Absci website. This link is provided for your convenience, but the content is the sole responsibility of its owner. Do you want to continue?
Return to the Absci website at any time by using the “Back” button on your web browser.
YES
NO